Big Pharma, little science? A bibliometric perspective on big pharma's R&D decline

Ismael Rafols, Michael M. Hopkins, Jarno Hoekman +4

There is a widespread perception that pharmaceutical R&D is facing a productivity crisis characterised by stagnation in the numbers of new drug approvals in the face of increasing…